APA (7th ed.) Citation

SJ, N., AJ, N., M, D., JJP, K., CM, B., KK, R., . . . MH, D. (2026). Obicetrapib in patients with heterozygous familial hypercholesterolemia: The BROOKLYN randomized clinical trial. Nature medicine, 32(3), 1052. https://doi.org/10.1038/s41591-025-04179-4

Chicago Style (17th ed.) Citation

SJ, Nicholls, et al. "Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia: The BROOKLYN Randomized Clinical Trial." Nature Medicine 32, no. 3 (2026): 1052. https://doi.org/10.1038/s41591-025-04179-4.

MLA (9th ed.) Citation

SJ, Nicholls, et al. "Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia: The BROOKLYN Randomized Clinical Trial." Nature Medicine, vol. 32, no. 3, 2026, p. 1052, https://doi.org/10.1038/s41591-025-04179-4.